Seeger Weiss Blog
Seeger Weiss Blog: Legal News and Analysis

Category : Recall

General Motors Recalls 1.4 million GM Vehicles Due to Ignition Switch Defect

March 13th, 2014

Recent reports allege a link between General Motors (GM) ignition switches to crashes, serious injury and even death. On February 13, 2014, GM recalled over 700,000 Chevrolet Cobalts and Pontiac vehicles. These models have a malfunction which allegedly cause the key to unintentionally slip from the run position when a car hits a bump or if the keychain is too heavy. This malfunction can cause the engine to shut off along with loss of power in steering, breaks and safety systems.

Later on February 25, GM broadened the recall to include additional Chevy, Pontiac and Saturn models. The total number of cars in the recall has reached over one million. The company has urged people not add any key chains to the key until the switches are replaced completely to ensure the ignition will not shut off.

Since then, there have been several lawsuits against GM. The lawsuits claim that the manufacturers at GM knew about the defect in its Chevrolet Cobalt in 2004. GM employees allegedly were told about most of the crashes, but failed to consider them a major problem until this year. GM said it would offer a free loaner car and up to $500 towards a new GM vehicle for those effected by the defect. If the owner of the vehicle is not replacing the car entirely, GM has offered to replace the ignition when new parts arrive on the expected date of April 7th.

Due to an increase in deaths and injuries linked to General Motors, the U.S Attorney’s Office in New York has opened a full criminal investigation and claim surrounding the GM ignition switch recall. If you or someone you know was involved in a crash or sustained injuries involving the aforementioned models, please contact us for a free consultation.

Seeger Weiss, LLP is a leader in consumer class action lawsuits.  With experienced lawyers and locations throughout the United States, our firm strives to provide the highest quality of service to our clients.  We treat each case with careful attention to ensure that consumers get the justice they deserve.  Seeger Weiss has office locations in New York, New Jersey, and Pennsylvania.

Video: CBS Philadelphia Reports on Defective DePuy Hip Implants

December 5th, 2011

A recent health report from CBS Philadelphia investigates DePuy Orthopaedics’ defective hip replacements, and asks, “Why were so many people being injured by implants that are FDA approved?” The  hip implants, which due to their design have been shown to lead to blood poisoning, were recalled in August 2010. Before they were however, they caused many of the patients who received them life-threatening conditions, toxic injuries and debilitating pain. Visit CBS Philadelphia to watch a video featuring two of these stories and read the entire report.

Seeger Weiss LLP is currently investigating the claims of those harmed by the DePuy ASR Hip Implant. If you or someone you know has suffered complications from the DePuy ASR Hip Implant, contact Seeger Weiss LLP today. An attorney with our award-winning drug injury class action practice will assist you in evaluating your claim. Attorney consultations incur no obligation on your part and all initial consultations are free of charge. Seeger Weiss LLP has office locations in New York, New Jersey, Pennsylvania and California.

Information about the 2012 Stryker hip replacement recall.

FDA refuses to approve another diet drug

November 11th, 2010

From the Washington Post blog, The Checkup:

The agency sent a letter to the drugmaker raising a variety of concerns about Qnexa, according to Vivus Inc., of Mountain View, Calif., which had sought the drug’s approval. The letter does not bode well for the drug winning approval.

The move was expected, given that an FDA advisory panel had voted against the drug’s approval in July because of evidence it may have adverse side effects, including increasing the risks for birth defects during pregnancy.

But the step is the latest in a series of setbacks in the effort to develop new weight-loss drugs. The FDA last week rejected approval of lorcaserin because of it appeared to cause tumors in rats. And earlier this month the agency forced the removal of the the drug Meridia from the market because it appears to increase the risk for heart attacks and strokes.

Litigation mounts over hip implant

October 15th, 2010

From the Wisconsin Law Journal:Edit

“We think it’s going to be a pretty big litigation,” agreed Chris Seeger, a principal at Seeger Weiss, a New York-based personal injury law firm.

DePuy sold about 93,000 ASR Hip Resurfacing Systems and ASR XL Acetabular Systems. The company has reported that about 12 percent of patients required revision surgery within five years after implantation.

Seeger said the problem appears to be with the metal-on-metal design of the device, which “seems not to adhere well in the hip joint.”

“The problem is that if there’s a surgical revision required, the whole thing has to be re-done,” he said. “That’s a nasty, messy surgery.”

If you’re looking for information about the 2012 Stryker hip implant recall, please visit

Ta-Nehisi Coates on the so-far ineffective struggle to create a safe weight loss pill

October 12th, 2010

Ta-Nehisi Coates on the so-far ineffective struggle to create a safe weight loss pill: “It’s still all a dream…I wonder what the long-term effects of weight-loss pill would be?”

Toy recall, report signal small-battery dangers

September 21st, 2010

Associated Press:

Swallowing button batteries can be fatal or cause serious harm, and research suggests that severe injuries in children, though relatively scarce, are on the rise.

Read the rest of this entry »